{"pmid":32502288,"title":"Melanoma defies 'lockdown': ongoing detection during Covid-19 in central London.","text":["Melanoma defies 'lockdown': ongoing detection during Covid-19 in central London.","The COVID-19 pandemic has presented significant challenges for Dermatology services, particularly the diagnosis and management of malignant melanoma (MM). Early detection and definitive surgical treatment are key to improving MM prognosis, and in England there is a suspected skin cancer referral pathway that facilitates specialist Dermatology assessment within two weeks. Here, we describe the impact of COVID-19 on MM detection, based on data from the a Dermatology Department in central London.","Clin Exp Dermatol","Schauer, A A","Kulakov, E L","Martyn-Simmons, C L","Bunker, C B","Edmonds, E","32502288"],"abstract":["The COVID-19 pandemic has presented significant challenges for Dermatology services, particularly the diagnosis and management of malignant melanoma (MM). Early detection and definitive surgical treatment are key to improving MM prognosis, and in England there is a suspected skin cancer referral pathway that facilitates specialist Dermatology assessment within two weeks. Here, we describe the impact of COVID-19 on MM detection, based on data from the a Dermatology Department in central London."],"journal":"Clin Exp Dermatol","authors":["Schauer, A A","Kulakov, E L","Martyn-Simmons, C L","Bunker, C B","Edmonds, E"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32502288","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1111/ced.14324","locations":["England","London","London"],"countries":["United Kingdom"],"countries_codes":["GBR|United Kingdom"],"topics":["Prevention"],"weight":1,"_version_":1668804508718727169,"score":9.490897,"similar":[{"pmid":32468229,"title":"Melanoma Screening Days During the Coronavirus Disease 2019 (COVID-19) Pandemic: Strategies to Adopt.","text":["Melanoma Screening Days During the Coronavirus Disease 2019 (COVID-19) Pandemic: Strategies to Adopt.","Melanoma is one of the most common cancers, with an increasing incidence worldwide. Disease stage represents the most important prognosis factor; therefore, early diagnosis is essential for melanoma patients' survival rates. Following the outbreak in China, the coronavirus disease 2019 (COVID-19) pandemic has spread all over the world and the majority of dermatological visits have been postponed. These measures could cause a delay in melanoma diagnosis and management leading to an increase of morbidity, mortality and healthcare costs. Herein we propose an alternative model of skin cancer screening and the organization of screening campaigns in order to detect malignant lesions early during this emergency period.","Dermatol Ther (Heidelb)","Villani, Alessia","Fabbrocini, Gabriella","Costa, Claudia","Scalvenzi, Massimiliano","32468229"],"abstract":["Melanoma is one of the most common cancers, with an increasing incidence worldwide. Disease stage represents the most important prognosis factor; therefore, early diagnosis is essential for melanoma patients' survival rates. Following the outbreak in China, the coronavirus disease 2019 (COVID-19) pandemic has spread all over the world and the majority of dermatological visits have been postponed. These measures could cause a delay in melanoma diagnosis and management leading to an increase of morbidity, mortality and healthcare costs. Herein we propose an alternative model of skin cancer screening and the organization of screening campaigns in order to detect malignant lesions early during this emergency period."],"journal":"Dermatol Ther (Heidelb)","authors":["Villani, Alessia","Fabbrocini, Gabriella","Costa, Claudia","Scalvenzi, Massimiliano"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32468229","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1007/s13555-020-00402-x","keywords":["dermatoscopy","early detection","melanoma","prevention","screening","skin cancer"],"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1668167109951094785,"score":245.21788},{"pmid":32500571,"title":"Reduction in skin cancer diagnosis, and overall cancer referrals, during the COVID-19 pandemic.","text":["Reduction in skin cancer diagnosis, and overall cancer referrals, during the COVID-19 pandemic.","The COVID-19 pandemic has led to a marked reduction in the number of patients accessing the UK's National Health Service (NHS) for emergency reasons(1) . The cause for this decline is as yet unknown, and likely to be multifactorial. We investigated whether there had been a similar reduction in urgent cancer referrals (known in England as the Two Week Wait (TWW) pathway) and subsequent diagnosis of skin cancer in our dermatology service.","Br J Dermatol","Earnshaw, C H","Hunter, H J A","McMullen, E","Griffiths, C E M","Warren, R B","32500571"],"abstract":["The COVID-19 pandemic has led to a marked reduction in the number of patients accessing the UK's National Health Service (NHS) for emergency reasons(1) . The cause for this decline is as yet unknown, and likely to be multifactorial. We investigated whether there had been a similar reduction in urgent cancer referrals (known in England as the Two Week Wait (TWW) pathway) and subsequent diagnosis of skin cancer in our dermatology service."],"journal":"Br J Dermatol","authors":["Earnshaw, C H","Hunter, H J A","McMullen, E","Griffiths, C E M","Warren, R B"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32500571","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1111/bjd.19267","locations":["GBR","England"],"countries":["United Kingdom"],"countries_codes":["GBR|United Kingdom"],"topics":["Prevention"],"weight":1,"_version_":1668804508760670208,"score":196.84273},{"pmid":32347761,"title":"The Danger of Neglecting Melanoma during the COVID-19 Pandemic.","text":["The Danger of Neglecting Melanoma during the COVID-19 Pandemic.","Due to the COVID-19 pandemic, planned medical and surgical activities are being postponed. For the dermatology community, this interruption to the healthcare system can lead to delays in the diagnosis and treatment of melanoma. Neglecting melanoma during this crisis can result in increased mortality, morbidity and healthcare costs. With the COVID-19 pandemic evolving and no clear solutions in sight, it is time for the prospective evaluation of teledermatology. However, dermatologists should be cautious and continue seeing patients with pigmented lesions in person due to the necessity of early surgical intervention.","J Dermatolog Treat","Gomolin, Tamar","Cline, Abigail","Handler, Marc Zachary","32347761"],"abstract":["Due to the COVID-19 pandemic, planned medical and surgical activities are being postponed. For the dermatology community, this interruption to the healthcare system can lead to delays in the diagnosis and treatment of melanoma. Neglecting melanoma during this crisis can result in increased mortality, morbidity and healthcare costs. With the COVID-19 pandemic evolving and no clear solutions in sight, it is time for the prospective evaluation of teledermatology. However, dermatologists should be cautious and continue seeing patients with pigmented lesions in person due to the necessity of early surgical intervention."],"journal":"J Dermatolog Treat","authors":["Gomolin, Tamar","Cline, Abigail","Handler, Marc Zachary"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32347761","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1080/09546634.2020.1762844","keywords":["covid-19","delayed diagnosis","melanoma","public health","telemedicine"],"topics":["Prevention"],"weight":1,"_version_":1666138495391891457,"score":180.42519},{"pmid":32416014,"title":"A targeted response to the COVID-19 pandemic: analysing effectiveness of remote consultations for triage and management of routine dermatology referrals.","text":["A targeted response to the COVID-19 pandemic: analysing effectiveness of remote consultations for triage and management of routine dermatology referrals.","New patient referrals from primary care into dermatology services usually enter via one of three routes: (i) 2 week wait for suspected serious skin malignancies, (ii) routine non-urgent cases and (iii) emergency referrals (via an on call service). All these patients are assessed via a face-to-face consultation, after various waiting times depending on their urgency.","Clin Exp Dermatol","Corden, E","Rogers, A","Woo, W A","Simmonds, R","Mitchell, C","32416014"],"abstract":["New patient referrals from primary care into dermatology services usually enter via one of three routes: (i) 2 week wait for suspected serious skin malignancies, (ii) routine non-urgent cases and (iii) emergency referrals (via an on call service). All these patients are assessed via a face-to-face consultation, after various waiting times depending on their urgency."],"journal":"Clin Exp Dermatol","authors":["Corden, E","Rogers, A","Woo, W A","Simmonds, R","Mitchell, C"],"date":"2020-05-17T11:00:00Z","year":2020,"_id":"32416014","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1111/ced.14289","topics":["Prevention"],"weight":1,"_version_":1666994545960681472,"score":162.84381},{"pmid":32314460,"title":"Challenges of COVID-19 pandemic for dermatology.","text":["Challenges of COVID-19 pandemic for dermatology.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new coronavirus responsible for the pandemic named coronavirus disease 2019 (COVID-19). The disease causes SARS with a significant morbidity and mortality. We provide a review with a focus on COVID-19 in dermatology. We discuss triage of suspected infectious patients, protection of medical doctors and nurses. We discuss the available data on cutaneous symptoms, although disease-specific symptoms have yet not been observed. COVID-19 is a challenge for the treatment of dermatologic patients, either with severe inflammatory disorders or with skin cancer. The consequences for systemic treatment are obvious but it will be most important to collect the clinical data for a better decision process. Last but not least, education in dermatology for students will not be temporarily possible in the classical settings. COVID-19, although not a skin disease, by itself has an immense impact on dermatology.","Dermatol Ther","Wollina, Uwe","32314460"],"abstract":["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new coronavirus responsible for the pandemic named coronavirus disease 2019 (COVID-19). The disease causes SARS with a significant morbidity and mortality. We provide a review with a focus on COVID-19 in dermatology. We discuss triage of suspected infectious patients, protection of medical doctors and nurses. We discuss the available data on cutaneous symptoms, although disease-specific symptoms have yet not been observed. COVID-19 is a challenge for the treatment of dermatologic patients, either with severe inflammatory disorders or with skin cancer. The consequences for systemic treatment are obvious but it will be most important to collect the clinical data for a better decision process. Last but not least, education in dermatology for students will not be temporarily possible in the classical settings. COVID-19, although not a skin disease, by itself has an immense impact on dermatology."],"journal":"Dermatol Ther","authors":["Wollina, Uwe"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32314460","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1111/dth.13430","keywords":["covid-19 pandemic","sars-cov-2","dermatology"],"topics":["Prevention"],"weight":1,"_version_":1666138493457268737,"score":158.12018}]}